“foundation-medicine” Archives

in
Entry Author Date Location
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation 05/06/20 National
FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer 04/20/20 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32 11/05/19 San Diego
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
What’s Hot in Boston Biotech 2019: The Photos 06/04/19 Boston
To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test 05/30/19 Boston
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September 05/16/19 Boston
Genetic Medicine: FDA OKs 2nd Cancer Drug That Targets DNA, Not Tissues 11/26/18 National
Guardant Health’s IPO Tops Range, Raising $238M for Cancer Tests 10/04/18 San Francisco
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine 06/19/18 Boston
Loxo Unveils More Data, Paves a Path Forward In Precision Oncology 06/02/18 National
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
CMS Starts to Cover Broad Cancer DNA Tests, Boosting Foundation, Thermo 03/19/18 Boston
Bristol-Myers Immune Drug Combo Hits Early Mark in Lung Cancer Study 02/05/18 New York
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal 12/22/17 San Diego
Will Foundation’s FDA, CMS Nod Help Cancer DNA Tests Break Through? 12/01/17 Boston
In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs 11/14/17 New York
Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More 06/09/17 National
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions 05/31/17 National
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Flatiron, Foundation Med Link Records of 20,000 Cancer Patients 11/03/16 New York
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Armed With Patent, Foundation Med Sues Diagnostic Rival Guardant 05/18/16 Boston
Page 1 of 4 next page »